(Q44973658)

English

A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

7 December 2017

Andrew W. Roberts

3

1 reference

Europe PubMed Central

7 December 2017

4

1 reference

Europe PubMed Central

7 December 2017

5

1 reference

Europe PubMed Central

7 December 2017

author name string

A P Grigg

1

1 reference

Europe PubMed Central

7 December 2017

M Brown

2

1 reference

Europe PubMed Central

7 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

7 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

7 December 2017

34

1 reference

Europe PubMed Central

7 December 2017

5

1 reference

Europe PubMed Central

7 December 2017

447-453

1 reference

Europe PubMed Central

7 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704614

0 references

Fungal infections after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Glucocorticoids and invasive fungal infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Prophylaxis and treatment of patients with aspergillosis: an overview, including the Royal Melbourne Hospital experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Cyclophosphamide metabolism is affected by azole antifungals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Congestive heart failure associated with itraconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Multidrug resistance in Aspergillus fumigatus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Fatal disseminated infection by Scedosporium prolificans during induction therapy for acute leukemia: a case report and literature review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

21 January 2018

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704614

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704614

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44973658&oldid=2060220442"